File(s) under permanent embargo
Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass
journal contributionposted on 2023-05-25, 23:05 authored by Adams, MJ, Cardigan, RA, Marchant, WA, Grocott, MPW, Mutch, M, Prudy, G, Mackie, IJ, Machin, SJ
Objective: To identify patients with poor tissue factor pathway inhibitor (TFPI) response to heparin and observe any association with increased risk of excessive coagulation activation, morbidity, or mortality.
Publication titleJournal of Cardiothoracic and Vascular Anesthesia
Rights statementThe definitive version is available at http://www.sciencedirect.com